Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly

Go Back to All Clinical Trials

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Fetal Atrioventricular Block
Age: Between 18 years - 50 years
Gender: Female

Other Inclusion Criteria:
1. Participants who are =18 years of age and provide written informed consent
2. Those who state willingness to comply with all study procedures and availablity for the duration of the study
3. Be <18 weeks pregnant at the time of enrollment
4. Ability to take oral medication and be willing to adhere to the dexamethasone and IVIG protocols.
5. Any positive titer of anti-Ro if a history of a previously affected child
6. Ability to perform Doppler fetal heart rate and rhythm monitoring in the ambulatory setting
7. Ability to send an audiotext message by cell phone

You may not be eligible for this study if the following are true:

1. Multi-fetal pregnancy
2. Known allergic reactions to components of IVIG, or dexamethasone or maternal IgA deficiency
3. Fetal conduction system disease already present in the current pregnancy
4. Mentally ill women
5. Women prisoners
6. Cognitively impaired women
7. Treatment with >20 mg/prednisone q day or with any dose of fluorinated steroids

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies